To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Cancer: Artificial Intelligence
Wednesday 29th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the use of AI tools in supporting the treatment and management of cancer in the NHS; and what steps they are taking to ensure that those tools improve patient outcomes while maintaining safety and data protection standards.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government recognises the significant potential of artificial intelligence (AI) to support the treatment and management of cancer across the National Health Service, particularly through improving diagnostic accuracy, supporting clinical decision making, and helping clinicians prioritise care more effectively.

The Department is focusing the £21 million AI Diagnostic Fund on the deployment of technologies in key, high-demand areas, such as chest X-Ray and chest computed tomography scans, to enable faster diagnosis and treatment of lung cancer in over half of acute trusts in England.

The Government and NHS England are committed to the safe, ethical, and evidence-based adoption of AI. All AI technologies used in the NHS must meet robust regulatory requirements, including approval from the Medicines and Healthcare products Regulation Agency, the National Institute for Health and Care Excellence, the Health Research Authority, and the Care Quality Commission, as well as UK General Data Protection Regulations, and the Data Protection Act 2018.

NHS organisations remain responsible for deciding whether to deploy AI technologies locally, based on clinical need, safety, value for money, and alignment with national standards. The Government will continue to work closely with NHS England, regulators, and clinicians to ensure AI is used in ways that improve cancer outcomes while maintaining the highest standards of safety, transparency, and data protection.


Written Question

Question Link

Wednesday 29th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department for Energy Security & Net Zero:

To ask His Majesty's Government what assessment they have made of the impact of AI-related data centre energy demand on energy infrastructure; and what steps they are taking to ensure energy demand from those data centres does not increase costs for consumers.

Answered by Lord Whitehead - Minister of State (Department for Energy Security and Net Zero)

It has not proved possible to respond to this question in the time available before Prorogation. I will correspond directly with the noble Lord.


Written Question
Diagnosis: Artificial Intelligence
Wednesday 29th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the reliability of AI systems in supporting medical diagnosis, particularly in cases where patient data is incomplete; and what steps they are taking to ensure that appropriate safeguards are in place to protect patient safety and support clinical decision-making.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government recognises the potential of artificial intelligence (AI) to support clinicians in medical diagnosis, while being clear that such technologies must be safe, effective, and used appropriately.

AI systems in healthcare are intended to support, not replace, clinical judgement. Their reliability depends in part on the quality and completeness of patient data, and the Government is clear that a qualified healthcare professional must remain involved in decision‑making. Managing risks associated with incomplete data requires both robust system design and wider improvements in how patient information is accessed and shared across the health and care system.

All AI technologies used for medical diagnosis in the National Health Service must comply with medical device regulations and clinical safety standards. These should specifically consider risks such as false positives, false negatives, and performance degradation where data are incomplete.

The Government is also improving data foundations through the development of a Single Patient Record, which aims to provide a clear, unified view of a patient’s history wherever they have received care. This will support safer, faster, and better‑informed clinical decision‑making by enabling seamless access across care settings, while building on existing systems such as Electronic Patient Records, Shared Care Records, and the Federated Data Platform.


Written Question
Cardiovascular Diseases: Diagnosis
Wednesday 29th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the role of AI tools in supporting the early detection and diagnosis of cardiovascular conditions; and what steps they are taking to support the safe and effective adoption of those technologies in the NHS.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is actively deploying artificial intelligence (AI) technologies across the National Health Service to support the earlier detection and diagnosis of cardiovascular conditions. We are supporting the safe and effective adoption of AI tools such as AI-assisted echocardiography, automated electrocardiogram interpretation and digital stethoscope recordings. We are supporting this through robust regulatory and assurance processes, closely aligned to the National Institute for Health and Care Excellence’s Evidence Standards Framework for Digital Health Technologies, ensuring that AI technologies are clinically validated and used to support, not replace, professional clinical judgement.


Written Question
NHS: Drugs
Wednesday 29th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department for Science, Innovation & Technology:

To ask His Majesty's Government what assessment they have made of the potential for AI technologies to accelerate drug discovery and development; and what steps they are taking to support innovation, investment and adoption in the NHS and UK life sciences sector.

Answered by Lord Vallance of Balham - Minister of State (Department for Energy Security and Net Zero)

Researchers in the UK are already pioneering AI-driven applications in drug discovery, and we are taking steps to capture the opportunities this presents. Backed by up to £137m of investment, DSIT's AI for Science Strategy recently launched government's first AI for Science Mission, which will focus on harnessing the technology to accelerate drug discovery and deploy new treatments faster. The Sovereign AI Unit also provided seed funding to the OpenBind consortium to generate foundational protein-ligand structural data to power the next era of AI for drug design.

The Life Sciences Sector Plan and 10-Year Health Plan set out our vision to harness UK science and support adoption of innovation throughout the NHS to drive better health. For example, the Health Innovation Network plays a vital role in connecting innovators with NHS systems and supporting health and social care teams to identify, test and implement new solutions at scale - having already supported over 4.9 million patients.

Across the board, our plans also strengthen investment opportunities and partnerships across data, discovery and clinical trials to drive a thriving UK life sciences sector. This is demonstrated most recently by Boehringer Ingelheim’s investment of £150 million in King’s Cross to build capacity in AI and Machine Learning.

Finally, the launch of the Single National Formulary will play a key role in supporting equitable access and adoption of the most clinically and cost-effective medicines across England.


Written Question
Children: Digital Technology
Wednesday 29th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department for Education:

To ask His Majesty's Government what assessment they have made of the impact of screen time and digital technology use on early childhood development; and what steps they are taking to support parents and early years providers in managing the use of such technologies among young children.

Answered by Baroness Smith of Malvern - Minister of State (Department for Work and Pensions)

On 27 March, the government published Best Start in Life advice about screen use for children aged 0 to 5, which is available on the Best Start in Life website.

​The advice is informed by an expert panel’s independent report, which draws on quantitative and qualitative research, including engagement with parents, carers and stakeholders. It emphasises that screen use should be carefully managed, with a focus on supporting healthy development, encouraging active play, sleep, and positive interactions, helping parents to make informed, balanced decisions about technology use.

Guidance on appropriate electronic device and screen usage for early years settings is available on the Help for Early Years Providers platform.

Following the publication of our new screen use advice, we will update our guidance for early years settings, to align and strengthen the information on screen use and digital literacy for early years practitioners.

We will take the next opportunity to reference the updated Help for Early Years Providers guidance in the Early Years Foundation Stage frameworks.


Written Question
Financial Services: Small Businesses
Tuesday 28th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the HM Treasury:

To ask His Majesty's Government what assessment they have made of the role of fintech firms in providing capital to support scaling businesses.

Answered by Lord Livermore - Financial Secretary (HM Treasury)

The UK is a world leader in Fintech, and attracted $3.6 billion of investment in 2025, second only to the US. The Government is committed to making the UK the world’s most technologically advanced global financial centre, and remaining a leading jurisdiction for fintech firms to start-up, scale and list.

Over the last decade, fintechs and specialist banks have commanded a materially higher share of new SME lending, and are an essential part of the UK's credit landscape, including access to working capital. The share of total nominal gross bank lending to SMEs by challenger and specialist banks in 2024 was 60%. Over the same period, business models and financial technology have also evolved substantially, with more competition both for business banking and credit provision, increasing the options available to small and medium-sized enterprises to invest in and grow their businesses.


Written Question
Artificial Intelligence: Legal Profession
Tuesday 28th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department for Science, Innovation & Technology:

To ask His Majesty's Government what assessment they have made of the use of AI tools to generate legal correspondence and documentation.

Answered by Baroness Lloyd of Effra - Baroness in Waiting (HM Household) (Whip)

While government has published general principles and guidance on the responsible use of AI, focused on use within government and the public sector, it has not made a specific assessment of the use of AI tools to generate legal correspondence and documentation in the wider public domain or in private sector legal practice.

Existing guidance and resources on the AI Knowledge Hub, which includes the AI Playbook, are intended to support public sector organisations to adopt AI safely, responsibly and effectively, by setting out principles, legal and ethical considerations, and practical support rather than evaluating or endorsing particular uses or tools.


Written Question
Energy: Artificial Intelligence
Tuesday 28th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department for Energy Security & Net Zero:

To ask His Majesty's Government what assessment they have made of the use of AI technologies in the modernisation of energy systems.

Answered by Lord Vallance of Balham - Minister of State (Department for Energy Security and Net Zero)

The Department is working at pace to understand and develop the opportunities AI brings to the energy system. The AI Clean Energy Strategy will be published in the autumn, and will set out next steps on reforms and a delivery roadmap.

In parallel, the Department has commissioned the AI and Clean Energy Champion to produce a review of AI opportunities in the electricity networks, due to conclude in June. This will study potential benefits and barriers to deployment.


Written Question
Artificial Intelligence: Copyright
Tuesday 28th April 2026

Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)

Question to the Department for Science, Innovation & Technology:

To ask His Majesty's Government what assessment they have made of the implications of the increasing use of AI tools in the creation and distribution of digital content for intellectual property frameworks and the UK's creative industries; and what steps they are taking to support innovation while protecting the rights of creators and rights holders.

Answered by Baroness Lloyd of Effra - Baroness in Waiting (HM Household) (Whip)

The Government recognises that there is an increasing use of AI tools and other forms of technical innovation by the creative industries in their creative process, including in the creation and distribution of digital content.

The Government believes that copyright laws must protect the UK’s position as a creative powerhouse while unlocking the extraordinary potential of AI-driven innovation to grow the economy and improve British lives. The Government published a Report and Impact Assessment on AI and copyright on 18 March, outlining the steps it is taking to move us forward in this area.